Back
UroGen Pharma Vs. Ciena Industry Stock Comparison
Sell
25
URGN
UroGen Pharma
Last Price:
$11.21
Seasonality Move:
-4.35%
Buy
56
CIEN
Ciena
Last Price:
$83.61
Seasonality Move:
6.54%
Sell
25
UroGen Pharma (URGN)
is a Sell
Is UroGen Pharma a Buy, Sell or Hold?
-
The current UroGen Pharma [URGN] share price is $11.21. The Score for URGN is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
-
URGN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
URGN Stock Price Chart
What is UroGen Pharma's stock price today?
-
The UroGen Pharma share price today is $11.21The current trend is relatively stagnant and URGN is experiencing buying pressure, which is a positive indicator for future bullish movement.
CIEN Stock Price Chart
URGN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.33 | Sell |
Relative Strength Index (14 RSI): | 48.15 | Sell |
Chaikin Money Flow: | 269756 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (10.73 - 12.25) | Sell |
Bollinger Bands (100): | (11.44 - 13.74) | Sell |
CIEN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.46 | Buy |
Relative Strength Index (14 RSI): | 56.72 | Buy |
Chaikin Money Flow: | -459839 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (72.93 - 88.15) | Buy |
Bollinger Bands (100): | (55.93 - 76.99) | Buy |
URGN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 10.8 | Buy |
20-day SMA: | 11.21 | Sell |
50-day SMA: | 11.77 | Sell |
200-day SMA: | 13.72 | Sell |
8-day EMA: | 10.88 | Buy |
20-day EMA: | 11.16 | Buy |
50-day EMA: | 11.74 | Sell |
200-day EMA: | 13.25 | Sell |
CIEN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 85.92 | Sell |
20-day SMA: | 83.04 | Buy |
50-day SMA: | 74.04 | Buy |
200-day SMA: | 57.28 | Buy |
8-day EMA: | 84.88 | Sell |
20-day EMA: | 82.54 | Buy |
50-day EMA: | 75.85 | Buy |
200-day EMA: | 61.59 | Buy |
UroGen Pharma Earnings Growth & URGN Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.42 per share, and an increase next year of $2.30 per share.
Ciena Earnings Growth & CIEN Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.38 per share, a decrease next quarter of $0.01 per share, an increase this year of $0.47 per share, and an increase next year of $1.01 per share.
UroGen Pharma Technical Analysis
Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Ciena Technical Analysis
Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |